Skip to main content
SpringerLink
Log in

Surveillance and Intervention in IPMN

  • Chapter
  • First Online:
Translational Pancreatic Cancer Research

Part of the book series: Molecular and Translational Medicine ((MOLEMED))

  • 378 Accesses

Abstract

The increasing use of cross-sectional imaging, increasing life expectancy, and a trend for healthy individuals to undergo “health checkups” with full-body magnetic resonance imaging (MRI) have markedly increased the detection of intraductal papillary mucinous neoplasms (IPMNs). IPMNs are a heterogeneous group of pancreatic cystic neoplasms arising from the proliferation of mucin-producing cells within the pancreatic ducts. Due to the potential for progression to invasive cancer, most patients with IPMN require long-term follow-up. The primary goal herein is to prevent malignancy and/or alleviate symptoms while avoiding unnecessary surgery. Currently, four guidelines, the 2015 American Gastroenterological Association (AGA), the 2017 International Association of Pancreatology (IAP), the 2018 American College of Gastroenterology (ACG), and the 2018 European Study Group on Cystic Tumours of the Pancreas, provide recommendations on surveillance and surgical resection based on symptoms and perceived risk of malignancy. In the present chapter, we will discuss diagnostic, surveillance, and treatment for IPMNs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Del Chiaro M, et al. European evidence-based guidelines on pancreatic cystic neoplasms. Gut. 2018; https://doi.org/10.1136/gutjnl-2018-316027.

  2. Adsay NV, et al. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an ‘intestinal’ pathway of carcinogenesis in the pancreas. Am J Surg Pathol. 2004; https://doi.org/10.1097/00000478-200407000-00001.

  3. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. Lyon: International Agency for Research on Cancer (IARC); 2010.

    Google Scholar 

  4. Tanaka M, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012; https://doi.org/10.1016/j.pan.2012.04.004.

  5. Allen PJ, et al. A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients. Ann Surg. 2006; https://doi.org/10.1097/01.sla.0000237652.84466.54.

  6. Kosmahl M, et al. Cystic neoplasms of the pancreas and tumor-like lesions with cystic features: a review of 418 cases and a classification proposal. Virchows Arch. 2004; https://doi.org/10.1007/s00428-004-1043-z.

  7. Lee CJ, et al. Risk of malignancy in resected cystic tumors of the pancreas ≤3 cm in size: is it safe to observe asymptomatic patients? A multi-institutional report. J Gastrointest Surg. 2008; https://doi.org/10.1007/s11605-007-0381-y.

  8. Ingkakul T, Warshaw AL, Fernández-Del Castillo C. Epidemiology of intraductal papillary mucinous neoplasms of the pancreas: sex differences between 3 geographic regions. Pancreas. 2011; https://doi.org/10.1097/MPA.0b013e31821f27fb.

  9. Khalid A, Brugge W. ACG practice guidelines for the diagnosis and management of neoplastic pancreatic cysts. Am J Gastroenterol. 2007; https://doi.org/10.1111/j.1572-0241.2007.01516.x.

  10. Tanaka M, et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology. 2017;17:738–53.

    Article  Google Scholar 

  11. Vege SS, Ziring B, Jain R, Moayyedi P. American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology. 2015; https://doi.org/10.1053/j.gastro.2015.01.015.

  12. Elta GH, Enestvedt BK, Sauer BG, Lennon AM. ACG clinical guideline: diagnosis and management of pancreatic cysts. Am J Gastroenterol. 2018; https://doi.org/10.1038/ajg.2018.14.

  13. Unit PS, Institutet K. European evidence-based guidelines on pancreatic cystic neoplasms. Gut. 2018; https://doi.org/10.1136/gutjnl-2018-316027.

  14. Schmidt CM, et al. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg. 2007; https://doi.org/10.1097/SLA.0b013e318155a9e5.

  15. Nagai K, et al. Intraductal papillary mucinous neoplasms of the pancreas: Clinicopathologic characteristics and long-term follow-up after resection. World J Surg. 2008; https://doi.org/10.1007/s00268-007-9281-2.

  16. Ohno E, et al. Intraductal papillary mucinous neoplasms of the pancreas: differentiation of malignant and benign tumors by endoscopic ultrasonography findings of mural nodules. Ann Surg. 2011; https://doi.org/10.1097/SLA.0b013e31819edle5.

  17. Nara S, et al. Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases. Pancreas. 2009; https://doi.org/10.1097/MPA.0b013e318181b90d.

  18. Marchegiani G, et al. IPMN involving the main pancreatic duct: biology, epidemiology, and long-term outcomes following resection. Ann Surg. 2015; https://doi.org/10.1097/SLA.0000000000000813.

  19. Hwang DW, et al. Clinicopathologic analysis of surgically proven intraductal papillary mucinous neoplasms of the pancreas in SNUH: a 15-year experience at a single academic institution. Langenbeck's Arch Surg. 2012; https://doi.org/10.1007/s00423-010-0674-6.

  20. Waters JA, et al. CT vs MRCP: optimal classification of IPMN type and extent. J Gastrointest Surg. 2008; https://doi.org/10.1007/s11605-007-0367-9.

  21. Crippa S, et al. Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. Clin Gastroenterol Hepatol. 2010; https://doi.org/10.1016/j.cgh.2009.10.001.

  22. Salvia R, et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg. 2004; https://doi.org/10.1097/01.sla.0000124386.54496.15.

  23. Suzuki Y, et al. Cystic neoplasm of the pancreas: a Japanese multiinstitutional study of intraductal papillary mucinous tumor and mucinous cystic tumor. Pancreas. 2004; https://doi.org/10.1097/00006676-200404000-00005.

  24. Lee S-Y, et al. Long-term follow up results of intraductal papillary mucinous tumors of pancreas. J Gastroenterol Hepatol. 2005;20:1379–84.

    Article  Google Scholar 

  25. Schnelldorfer T, et al. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas. Arch Surg. 2008; https://doi.org/10.1001/archsurg.143.7.639.

  26. Kim SC, et al. Intraductal papillary mucinous neoplasm of the pancreas: clinical characteristics and treatment outcomes of 118 consecutive patients from a single center. J Hepato-Biliary-Pancreat Surg. 2008; https://doi.org/10.1007/s00534-007-1231-8.

  27. Sahora K, et al. Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series. Ann Surg. 2013; https://doi.org/10.1097/SLA.0b013e3182a18f48.

  28. Goh BKP, et al. Evaluation of the Sendai and 2012 international consensus guidelines based on cross-sectional imaging findings performed for the initial triage of mucinous cystic lesions of the pancreas: a single institution experience with 114 surgically treated patient. Am J Surg. 2014;208:202–9.

    Article  Google Scholar 

  29. Aso T, et al. ‘High-risk stigmata’ of the 2012 international consensus guidelines correlate with the malignant grade of branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreas. 2014; https://doi.org/10.1097/MPA.0000000000000199.

  30. Roch AM, et al. International consensus guidelines parameters for the prediction of malignancy in intraductal papillary mucinous neoplasm are not properly weighted and are not cumulative. HPB. 2014; https://doi.org/10.1111/hpb.12305.

  31. Jang JY, et al. Validation of international consensus guidelines for the resection of branch duct-type intraductal papillary mucinous neoplasms. Br J Surg. 2014;101:686–92.

    Article  CAS  Google Scholar 

  32. Fritz S, et al. Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk. Ann Surg. 2014; https://doi.org/10.1097/SLA.0000000000000980.

  33. Nguyen AH, et al. Current recommendations for surveillance and surgery of intraductal papillary mucinous neoplasms may overlook some patients with cancer. J Gastrointest Surg. 2015; https://doi.org/10.1007/s11605-014-2693-z.

  34. Schaberg KB, Dimaio MA, Longacre TA. Intraductal papillary mucinous neoplasms often contain epithelium from multiple subtypes and/or are unclassifiable. Am J Surg Pathol. 2016; https://doi.org/10.1097/PAS.0000000000000528.

  35. Carr NJ, Robin LH. WHO classification of tumors of the digestive system. 4th ed. Lyon: IARC; 2010. https://doi.org/10.6061/clinics/2018/e499.

    Book  Google Scholar 

  36. Beger HG, Nakao A, Neoptolemos JP, Shu You Peng MGS. Pancreatic cancer cystic neoplasms and endocrine tumors: Wiley-Blackwell; 2015.

    Google Scholar 

  37. Basturk O, et al. A revised classification system and recommendations from the Baltimore consensus meeting for neoplastic precursor lesions in the pancreas. Am J Surg Pathol. 2015; https://doi.org/10.1097/PAS.0000000000000533.

  38. Terris B, et al. Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions. J Pathol. 2002; https://doi.org/10.1002/path.1146.

  39. Adsay NV, et al. Colloid (mucinous noncystic) carcinoma of the pancreas. Am J Surg Pathol. 2001; https://doi.org/10.1097/00000478-200101000-00003.

  40. Distler M, et al. Pathohistological subtype predicts survival in patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann Surg. 2013; https://doi.org/10.1097/SLA.0b013e318287ab73.

  41. Furukawa T, et al. Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas. Gut. 2011;60:509–16.

    Article  Google Scholar 

  42. Yopp AC, et al. Invasive carcinoma arising in intraductal papillary mucinous neoplasms of the pancreas: a matched control study with conventional pancreatic ductal adenocarcinoma. Ann Surg. 2011; https://doi.org/10.1097/SLA.0b013e318214bcb4.

  43. Volkan Adsay N, Adair CF, Heffess CS, Klimstra DS. Intraductal oncocytic papillary neoplasms of the pancreas. Am J Surg Pathol. 1996; https://doi.org/10.1097/00000478-199608000-00007.

  44. Del Chiaro M, Verbeke C. Intraductal papillary mucinous neoplasms of the pancreas: reporting clinically relevant features. Histopathology. 2017; https://doi.org/10.1111/his.13131.

  45. Kölby D, Thilén J, Andersson R, Sasor A, Ansari D. Multifocal intraductal tubulopapillary neoplasm of the pancreas with total pancreatectomy: report of a case and review of literature. Int J Clin Exp Pathol. 2015;8:9672.

    PubMed  PubMed Central  Google Scholar 

  46. Suda K, et al. Variant of intraductal carcinoma (with scant mucin production) is of main pancreatic duct origin: a clinicopathological study of four patients. Am J Gastroenterol. 1996; https://doi.org/10.1016/j.meatsci.2005.09.014.

  47. Rooney SL, Shi J. Intraductal tubulopapillary neoplasm of the pancreas an update from a pathologist’s perspective. Arch Pathol Lab Med. 2016; https://doi.org/10.5858/arpa.2016-0207-RA.

  48. Fernández-del Castillo C, et al. Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients. Arch Surg. 2003; https://doi.org/10.1001/archsurg.138.4.427.

  49. Sakorafas GH, Sarr MG. Cystic neoplasms of the pancreas; What a clinician should know. Cancer Treat Rev. 2005; https://doi.org/10.1016/j.ctrv.2005.09.001.

  50. Stark A, Donahue TR, Reber HA, Joe Hines O. Pancreatic cyst disease a review. J Am Med Assoc. 2016; https://doi.org/10.1001/jama.2016.4690.

  51. Tsutsumi K, et al. A history of acute pancreatitis in intraductal papillary mucinous neoplasms of the pancreas is a potential predictive factor for malignant papillary subtype. Pancreatology. 2010; https://doi.org/10.1159/000320696.

  52. Ingkakul T, et al. Predictors of the presence of concomitant invasive ductal carcinoma in intraductal papillary mucinous neoplasm of the pancreas. Ann Surg. 2010; https://doi.org/10.1097/SLA.0b013e3181c5ddc3.

  53. Tanaka M, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006; https://doi.org/10.1159/000090023.

  54. Del Chiaro M, et al. European experts consensus statement on cystic tumours of the pancreas. Dig Liver Dis. 2013;45:703–11.

    Article  Google Scholar 

  55. Kim YC, et al. Comparison of MRI and endoscopic ultrasound in the characterization of pancreatic cystic lesions. AJR Am J Roentgenol. 2010; https://doi.org/10.2214/AJR.09.3985.

  56. Jones MJ, et al. Imaging of indeterminate pancreatic cystic lesions: a systematic review. Pancreatology. 2013; https://doi.org/10.1016/j.pan.2013.05.007.

  57. Sultana A, et al. What is the best way to identify malignant transformation within pancreatic IPMN: a systematic review and meta-analyses. Clin Transl Gastroenterol. 2015; https://doi.org/10.1038/ctg.2015.60.

  58. Tirkes T, et al. Cystic neoplasms of the pancreas; findings on magnetic resonance imaging with pathological, surgical, and clinical correlation. Abdom Imaging. 2014; https://doi.org/10.1007/s00261-014-0138-5.

  59. Lee LS, et al. EUS-guided fine needle aspiration of pancreatic cysts: a retrospective analysis of complications and their predictors. Clin Gastroenterol Hepatol. 2005; https://doi.org/10.1016/S1542-3565(04)00618-4.

  60. Brugge WR, et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology. 2004; https://doi.org/10.1053/j.gastro.2004.02.013.

  61. Thornton GD, et al. Endoscopic ultrasound guided fine needle aspiration for the diagnosis of pancreatic cystic neoplasms: a meta-analysis. Pancreatology. 2013; https://doi.org/10.1016/j.pan.2012.11.313.

  62. Ngamruengphong S, Bartel MJ, Raimondo M. Cyst carcinoembryonic antigen in differentiating pancreatic cysts: a meta-analysis. Dig Liver Dis. 2013; https://doi.org/10.1016/j.dld.2013.05.002.

  63. Pitman MB, Centeno BA, Ali SZ, Genevay M, Stelow E, Mino-Kenudson M, Castillo C F-d, Schmidt CM, Brugge W, Layfield L. Standardized terminology and nomenclature for pancreatobiliary cytology: the Papanicolaou Society of Cytopathology Guidelines. Diagn Cytopathol. 2014;42:338–50.

    Article  Google Scholar 

  64. Matthaei H, et al. miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts. Clin Cancer Res. 2012; https://doi.org/10.1158/1078-0432.CCR-12-0035.

  65. Wu J, et al. Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc Natl Acad Sci. 2011; https://doi.org/10.1073/pnas.1118046108.

  66. Amato E, et al. Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas. J Pathol. 2014; https://doi.org/10.1002/path.4344.

  67. Wu J, et al. Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med. 2011; https://doi.org/10.1126/scitranslmed.3002543.

  68. Dal Molin M, et al. Clinicopathological correlates of activating gnas mutations in intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann Surg Oncol. 2013; https://doi.org/10.1245/s10434-013-3096-1.

  69. Ryu JK, et al. Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma. Pancreatology. 2011; https://doi.org/10.1159/000329183.

  70. Caponi S, et al. The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms. Ann Oncol. 2013; https://doi.org/10.1093/annonc/mds513.

  71. Grüner BM, et al. MALDI imaging mass spectrometry for in situ proteomic analysis of preneoplastic lesions in pancreatic cancer. PLoS One. 2012; https://doi.org/10.1371/journal.pone.0039424.

  72. Mann BF, Goetz JA, House MG, Schmidt CM, Novotny MV. Glycomic and proteomic profiling of pancreatic cyst fluids identifies Hyperfucosylated Lactosamines on the N -linked Glycans of overexpressed glycoproteins. Mol Cell Proteomics. 2012; https://doi.org/10.1074/mcp.M111.015792.

  73. Corcos O, et al. Proteomic assessment of markers for malignancy in the mucus of intraductal papillary mucinous neoplasms of the pancreas. Pancreas. 2012; https://doi.org/10.1097/MPA.0b013e3182289356.

  74. Lévy P, Rebours V. The role of endoscopic ultrasound in the diagnosis of cystic lesions of the pancreas. Visc Med. 2018;34:192–6.

    Article  Google Scholar 

  75. Yamashita Y, et al. Usefulness of contrast-enhanced endoscopic sonography for discriminating mural nodules from mucous clots in intraductal papillary mucinous neoplasms a single-center prospective study. J Ultrasound Med. 2013; https://doi.org/10.7863/jum.2013.32.1.61.

  76. Matsumoto K, et al. Performance of novel tissue harmonic echo imaging using endoscopic ultrasound for pancreatic diseases. Endosc Int Open. 2016; https://doi.org/10.1055/s-0034-1393367.

  77. Tsujino T, et al. In vivo identification of pancreatic cystic neoplasms with needle-based confocal laser endomicroscopy. Best Pract Res Clin Gastroenterol. 2015; https://doi.org/10.1016/j.bpg.2015.06.006.

  78. Napoléon B, et al. A novel approach to the diagnosis of pancreatic serous cystadenoma: needle-based confocal laser endomicroscopy. Endoscopy. 1998; https://doi.org/10.1055/s-0034-1390693.

  79. Napoleon B, et al. In vivo characterization of pancreatic cystic lesions by needle-based confocal laser endomicroscopy (nCLE): proposition of a comprehensive nCLE classification confirmed by an external retrospective evaluation. Surg Endosc Other Interv Tech. 2016; https://doi.org/10.1007/s00464-015-4510-5.

  80. Kadayifci A, Atar M, Basar O, Forcione DG, Brugge WR. Needle-based confocal laser endomicroscopy for evaluation of cystic neoplasms of the pancreas. Dig Dis Sci. 2017; https://doi.org/10.1007/s10620-017-4521-2.

  81. Krishna SG, et al. In vivo and ex vivo confocal endomicroscopy of pancreatic cystic lesions: a prospective study. World J Gastroenterol. 2017; https://doi.org/10.3748/wjg.v23.i18.3338.

  82. Jais B, Rebours V, Malleo G, Salvia R, Fontana M, Maggino L, Bassi C, Manfredi R, Moran R, Lennon AM, Zaheer A, Wolfgang C, Hruban R, Marchegiani G, Fernández Del Castillo C, Brugge W, Ha Y, Kim MH, Oh D, Hirai I, Kimura W, Jang JY, Kim SW, Jung W, Kang HLP. Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas). Gut. 2015;65:1–8.

    Google Scholar 

  83. Zhang ML, et al. Moray micro forceps biopsy improves the diagnosis of specific pancreatic cysts. Cancer Cytopathol. 2018; https://doi.org/10.1002/cncy.21988.

  84. Yamaguchi T, Kita E, Mikata RHT. Peroral Pancreatoscopy (POPS): Springer; 2019. https://doi.org/10.1007/978-4-431-56009-8_31.

  85. Sauvanet A, Couvelard A, Belghiti J. Role of frozen section assessment for intraductal papillary and mucinous tumor of the pancreas. World J Gastrointest Surg. 2010; https://doi.org/10.4240/wjgs.v2.i10.352.

  86. Eguchi H, et al. Role of intraoperative cytology combined with histology in detecting continuous and skip type intraductal cancer existence for intraductal papillary mucinous carcinoma of the pancreas. Cancer. 2006; https://doi.org/10.1002/cncr.22301.

  87. Vege SS, Ziring B, Jain R, Moayyedi P. American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology. 2015;148:819–22.

    Article  Google Scholar 

  88. Rubio-Tapia A, et al. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013; https://doi.org/10.1038/ajg.2013.79.

  89. Scholten L, et al. Surgical management of intraductal papillary mucinous neoplasm with main duct involvement: an international expert survey and case-vignette study. Surgery (United States). 2018; https://doi.org/10.1016/j.surg.2018.01.025.

  90. Ito T, et al. The distribution of atypical epithelium in main-duct type intraductal papillary mucinous neoplasms of the pancreas. J Hepatobiliary Pancreat Sci. 2011; https://doi.org/10.1007/s00534-010-0337-6.

  91. Watanabe Y, et al. Validity of the management strategy for intraductal papillary mucinous neoplasm advocated by the international consensus guidelines 2012: a retrospective review. Surg Today. 2016; https://doi.org/10.1007/s00595-015-1292-2.

  92. He J, et al. Is it necessary to follow patients after resection of a benign pancreatic intraductal papillary mucinous neoplasm? J Am Coll Surg. 2013; https://doi.org/10.1016/j.jamcollsurg.2012.12.026.

  93. Tamura K, et al. Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review. Ann Surg. 2014; https://doi.org/10.1097/SLA.0b013e3182a690ff.

  94. Fritz S, et al. Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas. Surgery. 2012; https://doi.org/10.1016/j.surg.2012.05.025.

  95. Shi C, et al. Increased prevalence of precursor lesions in familial pancreatic cancer patients. Clin Cancer Res. 2009; https://doi.org/10.1158/1078-0432.CCR-09-0004.

  96. First GO. European evidence-based guidelines on pancreatic cystic neoplasms. Gut. gutjnl-2018-316027. 2018; https://doi.org/10.1136/gutjnl-2018-316027.

  97. Raut CP, et al. Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival. Ann Surg Oncol. 2006; https://doi.org/10.1245/ASO.2006.05.002.

  98. Farrell JJ, Fernández-Del Castillo C. Pancreatic cystic neoplasms: management and unanswered questions. Gastroenterology. 2013; https://doi.org/10.1053/j.gastro.2013.01.073.

  99. Kang MJ, et al. Long-term prospective cohort study of patients undergoing pancreatectomy for intraductal papillary mucinous neoplasm of the pancreas. Ann Surg. 2014; https://doi.org/10.1097/SLA.0000000000000470.

  100. Kang MJ, et al. Long-term prospective cohort study of patients undergoing pancreatectomy for intraductal papillary mucinous neoplasm of the pancreas implications for postoperative surveillance. Ann Surg. 2014; https://doi.org/10.1097/SLA.0000000000000470.

  101. Ideno N, et al. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype. Ann Surg. 2013; https://doi.org/10.1097/SLA.0b013e31828cd008.

  102. Hirono S, et al. Long-term surveillance is necessary after operative resection for intraductal papillary mucinous neoplasm of the pancreas. Surgery (United States). 2016; https://doi.org/10.1016/j.surg.2016.04.007.

  103. Miyasaka Y, et al. Predictive factors for the metachronous development of high-risk lesions in the remnant pancreas after partial pancreatectomy for intraductal papillary mucinous neoplasm. Ann Surg. 2016; https://doi.org/10.1097/SLA.0000000000001368.

  104. Yamaguchi K, et al. Intraductal papillary neoplasm of the pancreas: a clinical review of 13 benign and four malignant tumours. Eur J Surg. 1999; https://doi.org/10.1080/110241599750007081.

  105. Reid-Lombardo KM, Mathis KL, Wood CM, Harmsen WS, Sarr MG. Frequency of extrapancreatic neoplasms in intraductal papillary mucinous neoplasm of the pancreas: implications for management. Ann Surg. 2010; https://doi.org/10.1097/SLA.0b013e3181b5ad1e.

  106. Elta GH, Enestvedt BK, Sauer BG, Marie Lennon A. ACG clinical guideline: diagnosis and management of pancreatic cysts. Am J Gastroenterol. 2018:1–16. https://doi.org/10.1038/ajg.2018.14.

  107. Macedo FIB, et al. The impact of surgeon volume on outcomes after pancreaticoduodenectomy: a meta-analysis. J Gastrointest Surg. 2017;21:1723–31.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Pancreas Institute Verona, Verona, Italy

    A. Balduzzi & G. Marchegiani

  2. Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology and Metabolism, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands

    N. C. M. van Huijgevoort, P. Fockens & J. E. van Hooft

  3. Department of Radiology and Nuclear Medicine, Amsterdam Gastroenterology and Metabolism, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands

    M. Engelbrecht & J. Stoker

  4. Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands

    J. Verheij

  5. Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands

    M. G. Besselink

Authors
  1. A. Balduzzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. C. M. van Huijgevoort
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Marchegiani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Engelbrecht
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Stoker
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. Verheij
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P. Fockens
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J. E. van Hooft
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M. G. Besselink
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. G. Besselink .

Editor information

Editors and Affiliations

  1. Department of Visceral, Vascular and Endocrine Surgery, University Hospital Halle (Saale), Halle (Saale), Sachsen-Anhalt, Germany

    Christoph W. Michalski

  2. Department of Internal Medicine I, University Hospital Halle (Saale), Halle (Saale), Sachsen-Anhalt, Germany

    Jonas Rosendahl

  3. Department of Internal Medicine I, University Hospital Halle (Saale), Halle (Saale), Sachsen-Anhalt, Germany

    Patrick Michl

  4. Department of Visceral, Vascular and Endocrine Surgery, University Hospital Halle (Saale), Halle (Saale), Sachsen-Anhalt, Germany

    Jörg Kleeff

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Balduzzi, A. et al. (2020). Surveillance and Intervention in IPMN. In: Michalski, C., Rosendahl, J., Michl, P., Kleeff, J. (eds) Translational Pancreatic Cancer Research. Molecular and Translational Medicine. Humana, Cham. https://doi.org/10.1007/978-3-030-49476-6_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-49476-6_2

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-030-49475-9

  • Online ISBN: 978-3-030-49476-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation